EGF promotes invasion by PANC-1 cells through Racl/ROS-dependent secretion and activation of MMP-2

被引:91
作者
Binker, Marcelo G. [1 ]
Binker-Cosen, Andres A. [1 ]
Richards, Daniel [1 ]
Oliver, Brenda [1 ]
Cosen-Binker, Laura I. [1 ]
机构
[1] CBRHC Res Ctr, RA-1426 Buenos Aires, DF, Argentina
关键词
PANC-1; cells; Epidermal growth factor (EGF); Rac1; Reactive oxygen species (ROS); Matrix metalloproteinase-2 (MMP-2); Cancer invasion; PANCREATIC-CANCER PROGRESSION; TUMOR PROGRESSION; PHOSPHATIDYLINOSITOL; 3-KINASE; EXTRACELLULAR-MATRIX; CARCINOMA CELLS; GELATINASE; GROWTH; MIGRATION; INHIBITION; EXPRESSION;
D O I
10.1016/j.bbrc.2008.12.080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Cancer metastasis involves tumor cells invading the surrounding tissue. Remodeling of tissue barriers depends on the ability of tumor cells to degrade the Surrounding Collagen matrix and then migrate through the matrix defects. Epidermal growth factor (EGF) has been shown to regulate tumor cell invasion through activation of matrix metalloproteinase-2 (MMP-2) in various tumor Cell types. In the present study, we investigated the role of MMP-2 and the signaling pathway involved in EGF-promoted invasion by human pancreatic cancer cells PANC-1. Using specific inhibitors, we found that EGF stimulation of these tumor cells induced secretion and activation of the collagenase MMP-2, which was required for EGF-stimulated basement membrane degradation and cell invasion. Our results also indicate that signaling events downstream of EGF receptor involved PI3K- and Src-dependent activation of Rac1, which mediated the NADPH-generated reactive oxygen species responsible for MMP-2 secretion and activation. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:445 / 450
页数:6
相关论文
共 28 条
[1]
Gelatinase-mediated migration and invasion of cancer cells [J].
Björklund, M ;
Koivunen, E .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (01) :37-69
[2]
ASSOCIATION BETWEEN EXPRESSION OF ACTIVATED 72-KILODALTON GELATINASE AND TUMOR SPREAD IN NON-SMALL-CELL LUNG-CARCINOMA [J].
BROWN, PD ;
BLOXIDGE, RE ;
STUART, NSA ;
GATTER, KC ;
CARMICHAEL, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (07) :574-578
[3]
Drug therapy: EGFR antagonists in cancer treatment [J].
Ciardiello, Fortunato ;
Tortora, Giampaolo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1160-1174
[4]
Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration [J].
Dise, Rebecca S. ;
Frey, Mark R. ;
Whitehead, Robert H. ;
Polk, D. Brent .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 294 (01) :G276-G285
[5]
Ellenrieder V, 2000, INT J CANCER, V85, P14, DOI 10.1002/(SICI)1097-0215(20000101)85:1<14::AID-IJC3>3.3.CO
[6]
2-F
[7]
Rho GTPases in cell biology [J].
Etienne-Manneville, S ;
Hall, A .
NATURE, 2002, 420 (6916) :629-635
[8]
EXPRESSION AND IN-SITU LOCALIZATION OF GENES-CODING FOR EXTRACELLULAR-MATRIX PROTEINS AND EXTRACELLULAR-MATRIX DEGRADING PROTEASES IN PANCREATIC-CANCER [J].
GRESS, TM ;
MULLERPILLASCH, F ;
LERCH, MM ;
FRIESS, H ;
BUCHLER, M ;
ADLER, G .
INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (04) :407-413
[9]
Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells [J].
Inoue, N ;
Takeshita, S ;
Gao, DY ;
Ishida, T ;
Kawashima, S ;
Akita, H ;
Tawa, R ;
Sakurai, H ;
Yokoyama, M .
ATHEROSCLEROSIS, 2001, 155 (01) :45-52
[10]
Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness [J].
Ito, H ;
Gardner-Thorpe, J ;
Zinner, MJ ;
Ashley, SW ;
Whang, EE .
SURGERY, 2003, 134 (02) :221-226